What does CUSIP 054754874 represent in this 13F holders report?

CUSIP 054754874 is the security identifier for AYTU - AYTU BIOPHARMA INC - COM NEW used to aggregate holder disclosures.

How many institutions held AYTU - AYTU BIOPHARMA INC - COM NEW in Q4 2021?

31 institutional investors reported AYTU - AYTU BIOPHARMA INC - COM NEW for Q4 2021. Use the holders table for investor-level position and value details.

AYTU BIOPHARMA INC - COM NEW (AYTU)

CUSIP: 054754874

Q4 2021 13F Holders as of 31 Dec 2021

Security type / class: Equity / COM NEW
Total 13F shares: 3,770,578
Total 13F value: $5,092,000
Share change: -468,163
Put/Call ratio: 9.7%
SEC-reported price per share: $1.35
Number of holders: 31
Value change: -$809,279
Number of buys: 13
Number of sells: 20

Security key

054754874

Report period

Q4 2021

Institutions

Top holders

AYTU full security history Ownership snapshot Full 13F holder table AYTU BIOPHARMA, INC SEC filings AYTU BIOPHARMA, INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AYTU - AYTU BIOPHARMA INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

0/15

Latest evidence

30 Sep 2021

3/4/5 13F Highest disclosed value: $5,017,808 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $5.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Disclosed position value Top 5

ARMISTICE CAPITAL, LLC $5.02M

VANGUARD GROUP INC $2.83M

RENAISSANCE TECHNOLOGIES LLC $1.9M

BlackRock Finance, Inc. $1.44M

MORGAN STANLEY $1.09M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	3/4/5 Director 3/4/5	— denominator unverified	$5,017,808 2,684,756 shares	—	20 Mar 2021
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$2,833,000 983,387 shares	—	30 Sep 2021
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$1,903,000 660,604 shares	—	30 Sep 2021
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$1,437,000 498,952 shares	—	30 Sep 2021
MORGAN STANLEY	13F Company 13F	— denominator unverified	$1,088,000 377,859 shares	—	30 Sep 2021
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$1,038,000 360,256 shares	—	30 Sep 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,770,578

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

-4

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 value	Q4 2021 value	Value change	Value Chg %